S311C D2DR variant: no association with schizophrenia

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

Physical review letters·2024

New insight into flavivirus maturation from structure/function studies of the yellow fever virus envelope protein complex.

mBio·2023

RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays.

Radiation research·2023

RENEB Inter-Laboratory Comparison 2021: The Cytokinesis-Block Micronucleus Assay.

Radiation research·2023

RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome Assay.

Radiation research·2023

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

Physical review letters·2022

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Confirmation of the HLA-B*35:642 Allele in a Brazilian Individual.

HLA·2026

Identification of the Novel HLA-G*01:71 Allele Using PolyseqOne Nanopore Sequencing Technology.

HLA·2026

Non-Coding c.*6C>T Variant in RBM8A Associated With Thrombocytopenia-Absent Radius (TAR) Syndrome in Three Indian Patients.

Clinical genetics·2026

Identification of a Novel HLA-B Allele, HLA-B*35:640, Discovered by Next-Generation Sequencing.

HLA·2026

Clinical and Genetic Spectrum of Filippi Syndrome: A Systematic Review of Published Case Reports and Case Series.

Health science reports·2026

Data mining revealed no other trinucleotide repeat expansion associated with the Huntington's disease biomarker (CAG).

Clinical parkinsonism & related disorders·2026

Related Experiment Videos

S311C D2DR variant: no association with schizophrenia

Related Concept Videos

Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

New insight into flavivirus maturation from structure/function studies of the yellow fever virus envelope protein complex.

RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays.

RENEB Inter-Laboratory Comparison 2021: The Cytokinesis-Block Micronucleus Assay.

RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome Assay.

Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Confirmation of the HLA-B*35:642 Allele in a Brazilian Individual.

Identification of the Novel HLA-G*01:71 Allele Using PolyseqOne Nanopore Sequencing Technology.

Non-Coding c.*6C>T Variant in RBM8A Associated With Thrombocytopenia-Absent Radius (TAR) Syndrome in Three Indian Patients.

Identification of a Novel HLA-B Allele, HLA-B*35:640, Discovered by Next-Generation Sequencing.

Clinical and Genetic Spectrum of Filippi Syndrome: A Systematic Review of Published Case Reports and Case Series.

Data mining revealed no other trinucleotide repeat expansion associated with the Huntington's disease biomarker (CAG).

Related Experiment Videos

S311C D2DR variant: no association with schizophrenia

Related Concept Videos

Related Articles